Please login to the form below

Not currently logged in


This page shows the latest virtual news and features for those working in and with pharma, biotech and healthcare.

Keytruda combo outshines Opdivo in kidney cancer

Keytruda combo outshines Opdivo in kidney cancer

However the huge momentum and weight of data behind Keytruda makes its expansion into this field a virtual inevitability.

Latest news

More from news
Approximately 5 fully matching, plus 160 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 48 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 18 fully matching, plus 97 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...